BioNTech-Pfizer say COVID-19 vaccine 100 pct effective on 12 to 15-year-olds

Agence France-Presse

Posted at Mar 31 2021 07:02 PM | Updated as of Mar 31 2021 07:13 PM

BioNTech-Pfizer said Wednesday their vaccine showed 100 percent efficacy against the coronavirus in 12 to 15 year olds, as they eye approval for adolescents to get the jabs before the next school year.

Phase 3 trials carried out on 2,260 adolescents in the United States "demonstrated 100 percent efficacy and robust antibody responses," the companies said in a statement.

More details to follow. 

RELATED VIDEO:

Watch more on iWantTFC